
Union Chimique Belge
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Description
UCB is a biopharma company that focuses on the research and development of medication for neurology and immunology diseases.
Investor Profile
Union Chimique Belge has made 11 investments, with 0 in the past 12 months and 27% as lead.
Stage Focus
- Series C (18%)
- Seed (18%)
- Series B (18%)
- Corporate Round (18%)
- Series A (18%)
- Series Unknown (9%)
Country Focus
- United States (64%)
- Canada (9%)
- Switzerland (9%)
- Spain (9%)
- Belgium (9%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Software
- Biopharma
- Health Diagnostics
- Medical Device
- Information Technology
- Therapeutics
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.